Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 Studies

Pembrolizumab, Medicine, Refractory (planetary science), Internal medicine, Oncology, Clinical endpoint, Lymphoma, Phases of clinical research, Surgery, Clinical trial, Immunotherapy, Cancer